GlassScriptPhysician profile
Jaime Tarbox Dunn
NPI 1720413222
$15,685.63
in general payments reported to CMS, 2019-2025
17 companies · $467 in 2025
The $467 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $6,814 · 2022: $7,007 · 2023: $721 · 2024: $678 · 2025: $467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,770 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,770.39 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $6,049.01 | 2021-2022 | |
| Vyne Pharmaceuticals INC. | $3,729.39 | 2021 | |
| Incyte Corporation | $1,225.56 | 2021-2025 | Opzelura, Opzelura |
| Janssen Biotech, INC. | $977.18 | 2021-2022 | |
| Epi Health, LLC | $900.00 | 2022 | |
| Abbvie INC. | $771.50 | 2021-2024 | |
| Dermavant Sciences, INC. | $549.23 | 2022-2024 | Vtama |
| Regeneron Healthcare Solutions, INC. | $521.52 | 2021-2024 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $318.25 | 2022-2023 | Sotyktu |
| Lilly USA, LLC | $212.10 | 2021-2025 | Ebglyss, Taltz |
| Organon LLC | $146.19 | 2025 | Vtama, Nexplanon |
| Mayne Pharma Commercial LLC | $93.98 | 2022-2024 | |
| Ucb, INC. | $80.15 | 2021 | |
| Novartis Pharmaceuticals Corporation | $65.08 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.19 | 2023 | Duobrii, Arazlo, Jublia |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $16.65 | 2021 | |
| Journey Medical Corporation | $12.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaime Dunn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.